Indications and uses
Temporarily relieves mild to moderate aches and pains of muscles and joints associated with: strains sprains simple backache arthritis bruises
Temporarily relieves mild to moderate aches and pains of muscles and joints associated with: strains sprains simple backache arthritis bruises
Adults 18 years and older: only use one patch at a time clean and dry affected area remove patch from backing film and apply to skin (see illustration) apply one patch to the affected area and leave in place for up to 8 to 12 hours if pain lasts after using the first patch, a second patch may be applied for up to another 8 to 12 hours do not use more than 2 patches per day do not use for more than 3 days in a row ...
store at 20 - 25 degrees Celsius (68-77 degrees Fahrenheit) avoid storing product in direct sunlight protect product from excessive moisture some individuals may not experience pain relief until several hours after applying the patch
Menthol 3%
Methyl salicylate 10% (NSAID : nonsteroidal anti-inflammatory drug)
Topical analgesic
Temporarily relieves mild to moderate aches and pains of muscles and joints associated with:
For external use only
This product contains an NSAID, which may cause stomach bleeding. The chance is small but higher if you:
ask a health professional before use. It is especially important not to use methyl salicylate at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.
If put in mouth, get medical help or contact a Poison Control Center right away. Package not child resistant. Dispose of the used patches after folding sticky ends together.
Adults 18 years and older:
Children under 18 years of age: do not use; this product has not been shown to work in children
alicyclic saturated hydrocarbon resin, baking cloth, film, mineral oil, polyisobutylene, polyisobutylene 1,200,000, styrene-isoprene-styrene block copolymer, synthetic aluminum silicate
Toll free 1-87-SALONPAS
www.salonpas.us
Hisamitsu
NDC#46581-670-05
for temporary relief of mild to moderate pain
Sore Muscle
Sprains
Backache
Joint Pain
Salonpas
Pain Relief Patch
APPLY FOR 8 - 12 HOURS
Menthol 3%
Methyl Salicylate 10%
Topical Analgesic
FDA APPROVED NON-PRESCRIPTION PAIN RELIEVING PATCH
EFFECTIVENESS CONFIRMED IN CLINICAL TRIAL
5 PATCHES
2 3/4" X 3 15/16" (7cm X 10cm)
Package not child resistant.
Keep out of reach of children.
*DO NOT USE MORE THAN ONE SALONPAS PATCH AT A TIME. SEE DIRECTIONS.
Hisamitsu
FREE SAMPLE
NOT FOR RE-SALE
minty scent
NDC#46581-670-99
for temporary relief of mild to moderate pain
Sore Muscle
Sprains
Backache
Joint Pain
1 Peel the center film.
2 Place on affected area.
3 Slide the film forward.
4 Slide the other film backward.
Salonpas
Pain Relief Patch
APPLY FOR 8 - 12 HOURS
Menthol 3%
Methyl Salicylate 10%
Topical Analgesic
FDA APPROVED NON-PRESCRIPTION PAIN RELIEVING PATCH
EFFECTIVENESS CONFIRMED IN CLINICAL TRIAL
1 patch
2 3/4" X 3 15/16" (7cm X 10cm)
Package not child resistant.
Keep out of reach of children.
*DO NOT USE MORE THAN ONE SALONPAS PATCH AT A TIME. SEE DIRECTIONS.
Manufactured by
Hisamitsu Pharmacetuical Co., Inc.
JAPAN SAGA TOSU
MADE IN JAPAN
Disributed by
Hisamitsu America, Inc.
Florham Park, NJ 07932
Hisamitsu
NDC#46581-670-06
for temporary relief of mild to moderate pain
Sore Muscle
Sprains
Backache
Joint Pain
BONUS PACK!
ONE FREE PATCH
Salonpas
Pain Relief Patch
APPLY FOR 8 - 12 HOURS
Menthol 3%
Methyl Salicylate 10%
Topical Analgesic
FDA APPROVED NON-PRESCRIPTION PAIN RELIEVING PATCH
EFFECTIVENESS CONFIRMED IN CLINICAL TRIAL
6 patches
2 3/4" X 3 15/16" (7cm X 10cm)
Package not child resistant.
Keep out of reach of children.
*DO NOT USE MORE THAN ONE SALONPAS PATCH AT A TIME. SEE DIRECTIONS.
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 46581-670-05 | EA - Each | 46581-670 | 1955154e-ed03-4725-aeba-f9b2fdf51bab | 1 | 2015-10-02 |
| 46581-670-20 | EA - Each | 46581-670 | 122c63a4-340f-4e7e-8304-bec6562569e9 | 1 | 2022-11-07 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| MENTHOL | ACTIVE INGREDIENT | L7T10EIP3A | 13 | |
| METHYL SALICYLATE | ACTIVE INGREDIENT | LAV5U5022Y | 13 | |
| MENTHOL | ACTIVE MOIETY | L7T10EIP3A | 13 | |
| SALICYLIC ACID | ACTIVE MOIETY | O414PZ4LPZ | 13 | |
| ALUMINUM SILICATE | INACTIVE INGREDIENT | T1FAD4SS2M | 13 | |
| MINERAL OIL | INACTIVE INGREDIENT | T5L8T28FGP | 13 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 46581-670 | 46581-670-15, 46581-670-20, 46581-670-06, 46581-670-05, 46581-670-03, 46581-670-01, 46581-670-99 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| MENTHOL | L7T10EIP3A | ACTIB |
| METHYL SALICYLATE | LAV5U5022Y | ACTIB |
| ALUMINUM SILICATE | T1FAD4SS2M | IACT |
| MINERAL OIL | T5L8T28FGP | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | FILM / TRANSDERMAL | 11.42 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | OINTMENT / TOPICAL | 9938 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SYSTEM / TOPICAL | 654.36 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SOAP / TOPICAL | 0.82 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SUSPENSION / TOPICAL | 82 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SUSPENSION / TOPICAL | 82 %w/w | ||
| ALUMINUM SILICATE | ALUMINUM SILICATE | T1FAD4SS2M | SYSTEM / TOPICAL | 19 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | OINTMENT / TOPICAL | 9938 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | GEL / TOPICAL | 2.5 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | CREAM / TOPICAL | 2772 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SUSPENSION / TOPICAL | 82 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | CREAM / TOPICAL | 2772 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | GEL / TOPICAL | 2.5 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SYSTEM / TRANSDERMAL | 6.09 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SPRAY / TOPICAL | 1379 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | FILM / TRANSDERMAL | 11.42 mg | ||
| ALUMINUM SILICATE | ALUMINUM SILICATE | T1FAD4SS2M | SYSTEM / TOPICAL | 19 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | LOTION / TOPICAL | 1428 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | OIL / TOPICAL | 43.29 %v/v | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | LOTION / TOPICAL | 1428 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | PASTE / TOPICAL | 47.5 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SPRAY / TOPICAL | 1379 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SYSTEM / TOPICAL | 654.36 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SPRAY / TOPICAL | 1379 mg | ||
| ALUMINUM SILICATE | ALUMINUM SILICATE | T1FAD4SS2M | SYSTEM / TOPICAL | 19 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | PASTE / TOPICAL | 47.5 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | LOTION / TOPICAL | 1428 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | OINTMENT / TOPICAL | 9938 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | OIL / TOPICAL | 43.29 %v/v | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | GEL / TOPICAL | 2.5 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | LOTION / TOPICAL | 1428 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | CREAM / TOPICAL | 2772 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SYSTEM / TRANSDERMAL | 6.09 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SYSTEM / TRANSDERMAL | 6.09 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | PASTE / TOPICAL | 47.5 %w/w | ||
| ALUMINUM SILICATE | ALUMINUM SILICATE | T1FAD4SS2M | SYSTEM / TOPICAL | 19 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | FILM / TRANSDERMAL | 11.42 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | CREAM / TOPICAL | 2772 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | PASTE / TOPICAL | 47.5 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SYSTEM / TOPICAL | 654.36 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | GEL / TOPICAL | 2.5 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | CREAM / TOPICAL | 2772 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SYSTEM / TRANSDERMAL | 6.09 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SOAP / TOPICAL | 0.82 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | OINTMENT / TOPICAL | 9938 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | PASTE / TOPICAL | 47.5 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SOAP / TOPICAL | 0.82 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SUSPENSION / TOPICAL | 82 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | FILM, EXTENDED RELEASE / TRANSDERMAL | 34 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | LOTION / TOPICAL | 1428 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | FILM, EXTENDED RELEASE / TRANSDERMAL | 34 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SUSPENSION / TOPICAL | 82 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SOAP / TOPICAL | 0.82 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SPRAY / TOPICAL | 1379 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | FILM, EXTENDED RELEASE / TRANSDERMAL | 34 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SPRAY / TOPICAL | 1379 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | LOTION / TOPICAL | 1428 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | LOTION / TOPICAL | 1428 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | OINTMENT / TOPICAL | 9938 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | LOTION / TOPICAL | 1428 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022029-001 | SALONPAS | MENTHOL; METHYL SALICYLATE | 3%;10% | PATCH / TOPICAL | RLD, RS | 2008-02-20 | |
| N022029-002 | SALONPAS | MENTHOL; METHYL SALICYLATE | 3%;10% | PATCH / TOPICAL | RLD, RS | 2012-11-05 |
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N022029-001 | 9233184 | 2027-08-01 | Drug product | 2016-02-11 | |
| N022029-001 | 8809615 | 2030-01-03 | Drug product | 2014-08-19 | |
| N022029-002 | 9233184 | 2027-08-01 | Drug product | 2016-02-11 | |
| N022029-002 | 8809615 | 2030-01-03 | Drug product | 2014-08-19 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N022029-001 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD, RS | 2008-02-20 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022029-002 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD, RS | 2012-11-05 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N022029-001 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD, RS | 2008-02-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022029-002 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD, RS | 2012-11-05 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022029-001 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD, RS | 2008-02-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022029-002 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD | 2012-11-05 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022029-001 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD, RS | 2008-02-20 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022029-002 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD | 2012-11-05 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022029-001 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD, RS | 2008-02-20 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022029-002 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD | 2012-11-05 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022029-001 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD, RS | 2008-02-20 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022029-002 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD | 2012-11-05 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022029-001 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD, RS | 2008-02-20 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022029-002 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD | 2012-11-05 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022029-001 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD, RS | 2008-02-20 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022029-002 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD | 2012-11-05 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022029-001 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD, RS | 2008-02-20 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022029-002 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD | 2012-11-05 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022029-001 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD, RS | 2008-02-20 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022029-002 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD | 2012-11-05 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022029-001 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD, RS | 2008-02-20 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022029-002 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD | 2012-11-05 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N022029-001 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD, RS | 2008-02-20 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N022029-002 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD | 2012-11-05 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022029-001 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD, RS | 2008-02-20 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022029-002 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD | 2012-11-05 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022029-001 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD, RS | 2008-02-20 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022029-002 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD | 2012-11-05 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022029-001 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD, RS | 2008-02-20 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022029-002 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD | 2012-11-05 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N022029-001 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD, RS | 2008-02-20 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N022029-002 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD | 2012-11-05 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022029-001 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD, RS | 2008-02-20 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022029-002 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD | 2012-11-05 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022029-001 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD, RS | 2008-02-20 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022029-002 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD | 2012-11-05 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N022029-001 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD, RS | 2008-02-20 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N022029-002 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD | 2012-11-05 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022029-001 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD, RS | 2008-02-20 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022029-002 | SALONPAS | 3%;10% | PATCH / TOPICAL | RLD | 2012-11-05 | 74a2ff9319b5… |
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N022029-001 | 9233184 | 2027-08-01 | Drug product | 2016-02-11 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022029-001 | 8809615 | 2030-01-03 | Drug product | 2014-08-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022029-002 | 9233184 | 2027-08-01 | Drug product | 2016-02-11 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022029-002 | 8809615 | 2030-01-03 | Drug product | 2014-08-19 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N022029-001 | 9233184 | 2027-08-01 | Drug product | 2016-02-11 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022029-001 | 8809615 | 2030-01-03 | Drug product | 2014-08-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022029-002 | 9233184 | 2027-08-01 | Drug product | 2016-02-11 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022029-002 | 8809615 | 2030-01-03 | Drug product | 2014-08-19 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022029-001 | 9233184 | 2027-08-01 | Drug product | 2016-02-11 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022029-001 | 8809615 | 2030-01-03 | Drug product | 2014-08-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022029-002 | 9233184 | 2027-08-01 | Drug product | 2016-02-11 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022029-002 | 8809615 | 2030-01-03 | Drug product | 2014-08-19 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022029-001 | 9233184 | 2027-08-01 | Drug product | 2016-02-11 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022029-001 | 8809615 | 2030-01-03 | Drug product | 2014-08-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022029-002 | 9233184 | 2027-08-01 | Drug product | 2016-02-11 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022029-002 | 8809615 | 2030-01-03 | Drug product | 2014-08-19 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022029-001 | 9233184 | 2027-08-01 | Drug product | 2016-02-11 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022029-001 | 8809615 | 2030-01-03 | Drug product | 2014-08-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022029-002 | 9233184 | 2027-08-01 | Drug product | 2016-02-11 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022029-002 | 8809615 | 2030-01-03 | Drug product | 2014-08-19 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022029-001 | 9233184 | 2027-08-01 | Drug product | 2016-02-11 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022029-001 | 8809615 | 2030-01-03 | Drug product | 2014-08-19 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022029-002 | 9233184 | 2027-08-01 | Drug product | 2016-02-11 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022029-002 | 8809615 | 2030-01-03 | Drug product | 2014-08-19 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022029-001 | 9233184 | 2027-08-01 | Drug product | 2016-02-11 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022029-001 | 8809615 | 2030-01-03 | Drug product | 2014-08-19 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022029-002 | 9233184 | 2027-08-01 | Drug product | 2016-02-11 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022029-002 | 8809615 | 2030-01-03 | Drug product | 2014-08-19 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022029-001 | 9233184 | 2027-08-01 | Drug product | 2016-02-11 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022029-001 | 8809615 | 2030-01-03 | Drug product | 2014-08-19 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022029-002 | 9233184 | 2027-08-01 | Drug product | 2016-02-11 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022029-002 | 8809615 | 2030-01-03 | Drug product | 2014-08-19 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022029-001 | 9233184 | 2027-08-01 | Drug product | 2016-02-11 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022029-001 | 8809615 | 2030-01-03 | Drug product | 2014-08-19 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022029-002 | 9233184 | 2027-08-01 | Drug product | 2016-02-11 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022029-002 | 8809615 | 2030-01-03 | Drug product | 2014-08-19 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022029-001 | 9233184 | 2027-08-01 | Drug product | 2016-02-11 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022029-001 | 8809615 | 2030-01-03 | Drug product | 2014-08-19 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022029-002 | 9233184 | 2027-08-01 | Drug product | 2016-02-11 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022029-002 | 8809615 | 2030-01-03 | Drug product | 2014-08-19 | 5bbf6a4d5a75… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Salonpas Pain Relief | MENTHOL, METHYL SALICYLATE | Hisamitsu Pharmaceutical Co., Inc. | 724bc4d3-0bc1-4275-a23b-4bbc62fbc0d2 | 2025-03-14 | Warnings | 46581-670-03 46581-670-06 46581-670-15 46581-670-05 46581-670-01 46581-670-99 46581-670-20 46581-670 46581067005 46581067020 46581067099 46581067015 46581067001 46581067006 46581067003 b15d7bd2-d065-4a54-af88-27518cc59143 724bc4d3-0bc1-4275-a23b-4bbc62fbc0d2 |
Adverse event summaries are temporarily unavailable. Other product information remains available.